GSK plc 13D/13G Filings for Concert Pharmaceuticals, Inc. (CNCE)

GSK plc 13D and 13G filings for Concert Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-02-14
5:01 pm
Unchanged
2019-12-3113GConcert Pharmaceuticals, Inc.
CNCE
GSK plc1,179,941
4.100%
0
(Unchanged)
Filing